Purchase Order 68HERH25P0101
Award Date
4/3/25
Potential Completion Date
5/3/25
Potential Value
$28K
Funding Federal Agency
Office of Land and Emergency Management
Contracting Federal Agency
Office of Acquisition Management
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63146, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $17,955,751.55 firm fixed-price delivery order was awarded to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., by the Department of State Bureau of Medical Services. The contract is for the provision of autoinjectors and associated training devices to be delivered globally to Department of State personnel through September 2028 under the Department's "MANDRAKE 3.0 IDIQ" contract. This single-award IDIQ contract vehicle has a total potential value of...
The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Division of Strategic National Stockpile (SNS) awarded a $9,920,853.00 definitive firm-fixed-price contract to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the emergency procurement of 140,010 DuoDote Single Dose Autoinjectors. This contract was awarded without any set-aside designation. Meridian Medical Technologies is a global provider of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
The Department of Health and Human Services (HHS) Office of the Administration for Strategic Preparedness and Response (ASPR) awarded a $129,680,169.60 firm-fixed-price contract to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the delivery of Atropine & Pralidoxime Chloride Injector, Single Dose Auto-Injectors for the Strategic National Stockpile. The contract has a base period of one year and two one-year option periods, with a total period of...
Meridian Medical Technologies, LLC was awarded a purchase order contract valued at $2,461 by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of a training device for nerve agent antidotes by December 27, 2023. No set-aside designation was used for this award. Meridian will provide one TRAINING DEVICE,DIA at its place of performance in Columbia, Maryland. Meridian is a manufacturer and provider of medical training services owned by Pfizer Inc., a large...
This is a $660,839.00 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Meridian Medical Technologies, LLC, a for-profit limited liability company that manufactures medical devices and provides medical training services. The contract has a completion date of February 15, 2019 and was awarded on August 1, 2018 without any set-aside designation. The contract was awarded under a Special...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,260.76 and is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024.
Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA).
The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00...
The federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, with a ceiling value of $1,345.77. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of October 28, 2024.
The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The fixed-price delivery order, valued at $5,240.52, was awarded on June 9, 2022, with a completion date of June 10, 2022.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...